ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.